miR-10a increases the cisplatin resistance of lung adenocarcinoma circulating tumor cells via targeting PIK3CA in the PI3K/Akt pathway

Circulating tumor cells (CTCs) that are shed from the primary tumor invade the blood stream or surrounding parenchyma to form new tumors. The present study aimed to explore the underlying mechanism of cisplatin resistance in lung adenocarcinoma CTCs and provide clinical treatment guidance for lung c...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Tonghai, Ren, Kangqi, Ding, Guanggui, Yang, Lin, Wen, Yuxin, Peng, Bin, Wang, Guangsuo, Wang, Zheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160533/
https://www.ncbi.nlm.nih.gov/pubmed/32186774
http://dx.doi.org/10.3892/or.2020.7547

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160533/
https://www.ncbi.nlm.nih.gov/pubmed/32186774
http://dx.doi.org/10.3892/or.2020.7547

Ejemplares similares